CFML
GILD icon

COMPASS FINANCIAL MANAGEMENT LLC’s Gilead Sciences GILD Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
+5,244
New +$691K 0.08% 230

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's GILD Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Gilead Sciences (GILD) in Q2 2026: 5,244 shares worth $671K. The stake represents 0.08% of the portfolio and ranks #230 among its holdings.

1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 5,244 shares of Gilead Sciences worth $671K as of Q2 2026.
  • Gilead Sciences was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Gilead Sciences made up 0.08% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #230 holding.
  • 1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.